nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanabenz—NISCH—Podofilox—Etoposide—urinary bladder cancer	0.0188	1	CbGdCrCtD
Guanabenz—CYP1A2—urine—urinary bladder cancer	0.0137	0.141	CbGeAlD
Guanabenz—NISCH—prostate gland—urinary bladder cancer	0.0124	0.128	CbGeAlD
Guanabenz—NISCH—smooth muscle tissue—urinary bladder cancer	0.00877	0.0907	CbGeAlD
Guanabenz—NISCH—urethra—urinary bladder cancer	0.00829	0.0857	CbGeAlD
Guanabenz—NISCH—vagina—urinary bladder cancer	0.00611	0.0632	CbGeAlD
Guanabenz—ADRA2C—prostate gland—urinary bladder cancer	0.00566	0.0585	CbGeAlD
Guanabenz—ADRA2C—seminal vesicle—urinary bladder cancer	0.00478	0.0495	CbGeAlD
Guanabenz—ADRA2A—prostate gland—urinary bladder cancer	0.00451	0.0467	CbGeAlD
Guanabenz—NISCH—lymph node—urinary bladder cancer	0.00395	0.0409	CbGeAlD
Guanabenz—ADRA2C—renal system—urinary bladder cancer	0.00385	0.0399	CbGeAlD
Guanabenz—ADRA2A—seminal vesicle—urinary bladder cancer	0.00382	0.0395	CbGeAlD
Guanabenz—ADRA2C—urethra—urinary bladder cancer	0.00379	0.0392	CbGeAlD
Guanabenz—CYP1A2—renal system—urinary bladder cancer	0.00334	0.0346	CbGeAlD
Guanabenz—ADRA2A—urethra—urinary bladder cancer	0.00302	0.0312	CbGeAlD
Guanabenz—ADRA2C—vagina—urinary bladder cancer	0.00279	0.0289	CbGeAlD
Guanabenz—ADRA2A—female reproductive system—urinary bladder cancer	0.00246	0.0255	CbGeAlD
Guanabenz—ADRA2A—vagina—urinary bladder cancer	0.00223	0.023	CbGeAlD
Guanabenz—ADRA2C—lymph node—urinary bladder cancer	0.00181	0.0187	CbGeAlD
Guanabenz—ADRA2A—lymph node—urinary bladder cancer	0.00144	0.0149	CbGeAlD
Guanabenz—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000739	0.000835	CcSEcCtD
Guanabenz—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00073	0.000825	CcSEcCtD
Guanabenz—Paraesthesia—Etoposide—urinary bladder cancer	0.000729	0.000824	CcSEcCtD
Guanabenz—Weight increased—Epirubicin—urinary bladder cancer	0.000728	0.000823	CcSEcCtD
Guanabenz—Weight decreased—Epirubicin—urinary bladder cancer	0.000724	0.000818	CcSEcCtD
Guanabenz—Dyspnoea—Etoposide—urinary bladder cancer	0.000723	0.000818	CcSEcCtD
Guanabenz—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.000722	0.000816	CcSEcCtD
Guanabenz—Vomiting—Thiotepa—urinary bladder cancer	0.000718	0.000812	CcSEcCtD
Guanabenz—Infestation NOS—Epirubicin—urinary bladder cancer	0.000713	0.000806	CcSEcCtD
Guanabenz—Infestation—Epirubicin—urinary bladder cancer	0.000713	0.000806	CcSEcCtD
Guanabenz—Rash—Thiotepa—urinary bladder cancer	0.000712	0.000805	CcSEcCtD
Guanabenz—Dermatitis—Thiotepa—urinary bladder cancer	0.000712	0.000805	CcSEcCtD
Guanabenz—Headache—Thiotepa—urinary bladder cancer	0.000708	0.0008	CcSEcCtD
Guanabenz—Decreased appetite—Etoposide—urinary bladder cancer	0.000705	0.000797	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000701	0.000792	CcSEcCtD
Guanabenz—Body temperature increased—Cisplatin—urinary bladder cancer	0.0007	0.000792	CcSEcCtD
Guanabenz—Fatigue—Etoposide—urinary bladder cancer	0.0007	0.000791	CcSEcCtD
Guanabenz—Pain—Etoposide—urinary bladder cancer	0.000694	0.000785	CcSEcCtD
Guanabenz—Constipation—Etoposide—urinary bladder cancer	0.000694	0.000785	CcSEcCtD
Guanabenz—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000688	0.000778	CcSEcCtD
Guanabenz—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000688	0.000778	CcSEcCtD
Guanabenz—Haemoglobin—Methotrexate—urinary bladder cancer	0.000688	0.000777	CcSEcCtD
Guanabenz—Haemorrhage—Methotrexate—urinary bladder cancer	0.000684	0.000773	CcSEcCtD
Guanabenz—Asthenia—Gemcitabine—urinary bladder cancer	0.000682	0.000771	CcSEcCtD
Guanabenz—Weight increased—Doxorubicin—urinary bladder cancer	0.000674	0.000761	CcSEcCtD
Guanabenz—Pruritus—Gemcitabine—urinary bladder cancer	0.000672	0.00076	CcSEcCtD
Guanabenz—Nausea—Thiotepa—urinary bladder cancer	0.000671	0.000759	CcSEcCtD
Guanabenz—Weight decreased—Doxorubicin—urinary bladder cancer	0.00067	0.000757	CcSEcCtD
Guanabenz—Feeling abnormal—Etoposide—urinary bladder cancer	0.000669	0.000756	CcSEcCtD
Guanabenz—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000668	0.000755	CcSEcCtD
Guanabenz—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000664	0.00075	CcSEcCtD
Guanabenz—Pruritus—Fluorouracil—urinary bladder cancer	0.000661	0.000747	CcSEcCtD
Guanabenz—Infestation NOS—Doxorubicin—urinary bladder cancer	0.00066	0.000746	CcSEcCtD
Guanabenz—Infestation—Doxorubicin—urinary bladder cancer	0.00066	0.000746	CcSEcCtD
Guanabenz—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000653	0.000738	CcSEcCtD
Guanabenz—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00065	0.000735	CcSEcCtD
Guanabenz—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000647	0.000731	CcSEcCtD
Guanabenz—Urticaria—Etoposide—urinary bladder cancer	0.000645	0.000729	CcSEcCtD
Guanabenz—Haemoglobin—Epirubicin—urinary bladder cancer	0.000644	0.000728	CcSEcCtD
Guanabenz—Abdominal pain—Etoposide—urinary bladder cancer	0.000641	0.000725	CcSEcCtD
Guanabenz—Body temperature increased—Etoposide—urinary bladder cancer	0.000641	0.000725	CcSEcCtD
Guanabenz—Haemorrhage—Epirubicin—urinary bladder cancer	0.00064	0.000724	CcSEcCtD
Guanabenz—Eye disorder—Methotrexate—urinary bladder cancer	0.000639	0.000723	CcSEcCtD
Guanabenz—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000639	0.000723	CcSEcCtD
Guanabenz—Tinnitus—Methotrexate—urinary bladder cancer	0.000638	0.000721	CcSEcCtD
Guanabenz—Asthenia—Cisplatin—urinary bladder cancer	0.000636	0.000718	CcSEcCtD
Guanabenz—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000631	0.000713	CcSEcCtD
Guanabenz—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000629	0.000711	CcSEcCtD
Guanabenz—Immune system disorder—Methotrexate—urinary bladder cancer	0.000618	0.000699	CcSEcCtD
Guanabenz—Dizziness—Fluorouracil—urinary bladder cancer	0.000618	0.000699	CcSEcCtD
Guanabenz—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000617	0.000697	CcSEcCtD
Guanabenz—Chills—Methotrexate—urinary bladder cancer	0.000614	0.000694	CcSEcCtD
Guanabenz—Diarrhoea—Cisplatin—urinary bladder cancer	0.000606	0.000685	CcSEcCtD
Guanabenz—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000605	0.000684	CcSEcCtD
Guanabenz—Vomiting—Gemcitabine—urinary bladder cancer	0.000604	0.000683	CcSEcCtD
Guanabenz—Rash—Gemcitabine—urinary bladder cancer	0.000599	0.000677	CcSEcCtD
Guanabenz—Dermatitis—Gemcitabine—urinary bladder cancer	0.000599	0.000677	CcSEcCtD
Guanabenz—Eye disorder—Epirubicin—urinary bladder cancer	0.000598	0.000676	CcSEcCtD
Guanabenz—Hypersensitivity—Etoposide—urinary bladder cancer	0.000598	0.000676	CcSEcCtD
Guanabenz—Tinnitus—Epirubicin—urinary bladder cancer	0.000597	0.000675	CcSEcCtD
Guanabenz—Malnutrition—Methotrexate—urinary bladder cancer	0.000596	0.000673	CcSEcCtD
Guanabenz—Erythema—Methotrexate—urinary bladder cancer	0.000596	0.000673	CcSEcCtD
Guanabenz—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000595	0.000673	CcSEcCtD
Guanabenz—Headache—Gemcitabine—urinary bladder cancer	0.000595	0.000673	CcSEcCtD
Guanabenz—Vomiting—Fluorouracil—urinary bladder cancer	0.000594	0.000672	CcSEcCtD
Guanabenz—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000592	0.00067	CcSEcCtD
Guanabenz—Rash—Fluorouracil—urinary bladder cancer	0.000589	0.000666	CcSEcCtD
Guanabenz—Dermatitis—Fluorouracil—urinary bladder cancer	0.000589	0.000665	CcSEcCtD
Guanabenz—Headache—Fluorouracil—urinary bladder cancer	0.000585	0.000662	CcSEcCtD
Guanabenz—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000584	0.00066	CcSEcCtD
Guanabenz—Asthenia—Etoposide—urinary bladder cancer	0.000582	0.000658	CcSEcCtD
Guanabenz—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000582	0.000658	CcSEcCtD
Guanabenz—Immune system disorder—Epirubicin—urinary bladder cancer	0.000578	0.000654	CcSEcCtD
Guanabenz—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000577	0.000652	CcSEcCtD
Guanabenz—Back pain—Methotrexate—urinary bladder cancer	0.000576	0.000651	CcSEcCtD
Guanabenz—Chills—Epirubicin—urinary bladder cancer	0.000574	0.000649	CcSEcCtD
Guanabenz—Pruritus—Etoposide—urinary bladder cancer	0.000574	0.000649	CcSEcCtD
Guanabenz—Nausea—Gemcitabine—urinary bladder cancer	0.000564	0.000638	CcSEcCtD
Guanabenz—Vomiting—Cisplatin—urinary bladder cancer	0.000563	0.000637	CcSEcCtD
Guanabenz—Vision blurred—Methotrexate—urinary bladder cancer	0.000561	0.000635	CcSEcCtD
Guanabenz—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.00056	0.000633	CcSEcCtD
Guanabenz—Rash—Cisplatin—urinary bladder cancer	0.000558	0.000631	CcSEcCtD
Guanabenz—Dermatitis—Cisplatin—urinary bladder cancer	0.000558	0.000631	CcSEcCtD
Guanabenz—Erythema—Epirubicin—urinary bladder cancer	0.000557	0.00063	CcSEcCtD
Guanabenz—Malnutrition—Epirubicin—urinary bladder cancer	0.000557	0.00063	CcSEcCtD
Guanabenz—Diarrhoea—Etoposide—urinary bladder cancer	0.000555	0.000628	CcSEcCtD
Guanabenz—Nausea—Fluorouracil—urinary bladder cancer	0.000555	0.000627	CcSEcCtD
Guanabenz—Eye disorder—Doxorubicin—urinary bladder cancer	0.000554	0.000626	CcSEcCtD
Guanabenz—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000553	0.000625	CcSEcCtD
Guanabenz—Tinnitus—Doxorubicin—urinary bladder cancer	0.000552	0.000624	CcSEcCtD
Guanabenz—Anaemia—Methotrexate—urinary bladder cancer	0.00055	0.000622	CcSEcCtD
Guanabenz—Flatulence—Epirubicin—urinary bladder cancer	0.000549	0.000621	CcSEcCtD
Guanabenz—Tension—Epirubicin—urinary bladder cancer	0.000547	0.000618	CcSEcCtD
Guanabenz—Nervousness—Epirubicin—urinary bladder cancer	0.000541	0.000612	CcSEcCtD
Guanabenz—Back pain—Epirubicin—urinary bladder cancer	0.000539	0.000609	CcSEcCtD
Guanabenz—Malaise—Methotrexate—urinary bladder cancer	0.000537	0.000607	CcSEcCtD
Guanabenz—Dizziness—Etoposide—urinary bladder cancer	0.000537	0.000607	CcSEcCtD
Guanabenz—Muscle spasms—Epirubicin—urinary bladder cancer	0.000536	0.000606	CcSEcCtD
Guanabenz—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000535	0.000605	CcSEcCtD
Guanabenz—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000534	0.000604	CcSEcCtD
Guanabenz—Leukopenia—Methotrexate—urinary bladder cancer	0.000533	0.000603	CcSEcCtD
Guanabenz—Chills—Doxorubicin—urinary bladder cancer	0.000532	0.000601	CcSEcCtD
Guanabenz—Nausea—Cisplatin—urinary bladder cancer	0.000526	0.000595	CcSEcCtD
Guanabenz—Vision blurred—Epirubicin—urinary bladder cancer	0.000525	0.000594	CcSEcCtD
Guanabenz—Cough—Methotrexate—urinary bladder cancer	0.00052	0.000588	CcSEcCtD
Guanabenz—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000517	0.000585	CcSEcCtD
Guanabenz—Vomiting—Etoposide—urinary bladder cancer	0.000516	0.000583	CcSEcCtD
Guanabenz—Malnutrition—Doxorubicin—urinary bladder cancer	0.000516	0.000583	CcSEcCtD
Guanabenz—Erythema—Doxorubicin—urinary bladder cancer	0.000516	0.000583	CcSEcCtD
Guanabenz—Anaemia—Epirubicin—urinary bladder cancer	0.000515	0.000582	CcSEcCtD
Guanabenz—Agitation—Epirubicin—urinary bladder cancer	0.000512	0.000579	CcSEcCtD
Guanabenz—Rash—Etoposide—urinary bladder cancer	0.000512	0.000578	CcSEcCtD
Guanabenz—Dermatitis—Etoposide—urinary bladder cancer	0.000511	0.000578	CcSEcCtD
Guanabenz—Headache—Etoposide—urinary bladder cancer	0.000508	0.000575	CcSEcCtD
Guanabenz—Flatulence—Doxorubicin—urinary bladder cancer	0.000508	0.000575	CcSEcCtD
Guanabenz—Chest pain—Methotrexate—urinary bladder cancer	0.000507	0.000573	CcSEcCtD
Guanabenz—Arthralgia—Methotrexate—urinary bladder cancer	0.000507	0.000573	CcSEcCtD
Guanabenz—Myalgia—Methotrexate—urinary bladder cancer	0.000507	0.000573	CcSEcCtD
Guanabenz—Tension—Doxorubicin—urinary bladder cancer	0.000506	0.000572	CcSEcCtD
Guanabenz—Malaise—Epirubicin—urinary bladder cancer	0.000503	0.000568	CcSEcCtD
Guanabenz—Discomfort—Methotrexate—urinary bladder cancer	0.000501	0.000566	CcSEcCtD
Guanabenz—Nervousness—Doxorubicin—urinary bladder cancer	0.000501	0.000566	CcSEcCtD
Guanabenz—Syncope—Epirubicin—urinary bladder cancer	0.0005	0.000565	CcSEcCtD
Guanabenz—Leukopenia—Epirubicin—urinary bladder cancer	0.000499	0.000564	CcSEcCtD
Guanabenz—Back pain—Doxorubicin—urinary bladder cancer	0.000499	0.000564	CcSEcCtD
Guanabenz—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000496	0.000561	CcSEcCtD
Guanabenz—Confusional state—Methotrexate—urinary bladder cancer	0.00049	0.000554	CcSEcCtD
Guanabenz—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00049	0.000554	CcSEcCtD
Guanabenz—Cough—Epirubicin—urinary bladder cancer	0.000486	0.00055	CcSEcCtD
Guanabenz—Vision blurred—Doxorubicin—urinary bladder cancer	0.000486	0.000549	CcSEcCtD
Guanabenz—Infection—Methotrexate—urinary bladder cancer	0.000483	0.000546	CcSEcCtD
Guanabenz—Nausea—Etoposide—urinary bladder cancer	0.000482	0.000545	CcSEcCtD
Guanabenz—Hypertension—Epirubicin—urinary bladder cancer	0.000481	0.000544	CcSEcCtD
Guanabenz—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000478	0.000541	CcSEcCtD
Guanabenz—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000477	0.000539	CcSEcCtD
Guanabenz—Anaemia—Doxorubicin—urinary bladder cancer	0.000477	0.000539	CcSEcCtD
Guanabenz—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000476	0.000538	CcSEcCtD
Guanabenz—Arthralgia—Epirubicin—urinary bladder cancer	0.000475	0.000536	CcSEcCtD
Guanabenz—Chest pain—Epirubicin—urinary bladder cancer	0.000475	0.000536	CcSEcCtD
Guanabenz—Myalgia—Epirubicin—urinary bladder cancer	0.000475	0.000536	CcSEcCtD
Guanabenz—Agitation—Doxorubicin—urinary bladder cancer	0.000474	0.000536	CcSEcCtD
Guanabenz—Anxiety—Epirubicin—urinary bladder cancer	0.000473	0.000535	CcSEcCtD
Guanabenz—Skin disorder—Methotrexate—urinary bladder cancer	0.000472	0.000534	CcSEcCtD
Guanabenz—Discomfort—Epirubicin—urinary bladder cancer	0.000469	0.00053	CcSEcCtD
Guanabenz—Malaise—Doxorubicin—urinary bladder cancer	0.000465	0.000526	CcSEcCtD
Guanabenz—Dry mouth—Epirubicin—urinary bladder cancer	0.000464	0.000525	CcSEcCtD
Guanabenz—Anorexia—Methotrexate—urinary bladder cancer	0.000463	0.000524	CcSEcCtD
Guanabenz—Syncope—Doxorubicin—urinary bladder cancer	0.000462	0.000523	CcSEcCtD
Guanabenz—Leukopenia—Doxorubicin—urinary bladder cancer	0.000462	0.000522	CcSEcCtD
Guanabenz—Confusional state—Epirubicin—urinary bladder cancer	0.000459	0.000519	CcSEcCtD
Guanabenz—Oedema—Epirubicin—urinary bladder cancer	0.000455	0.000514	CcSEcCtD
Guanabenz—Hypotension—Methotrexate—urinary bladder cancer	0.000454	0.000513	CcSEcCtD
Guanabenz—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000453	0.000512	CcSEcCtD
Guanabenz—Infection—Epirubicin—urinary bladder cancer	0.000452	0.000511	CcSEcCtD
Guanabenz—Cough—Doxorubicin—urinary bladder cancer	0.00045	0.000509	CcSEcCtD
Guanabenz—Shock—Epirubicin—urinary bladder cancer	0.000448	0.000506	CcSEcCtD
Guanabenz—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000446	0.000504	CcSEcCtD
Guanabenz—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000445	0.000504	CcSEcCtD
Guanabenz—Hypertension—Doxorubicin—urinary bladder cancer	0.000445	0.000503	CcSEcCtD
Guanabenz—Tachycardia—Epirubicin—urinary bladder cancer	0.000444	0.000502	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000443	0.000501	CcSEcCtD
Guanabenz—Skin disorder—Epirubicin—urinary bladder cancer	0.000442	0.0005	CcSEcCtD
Guanabenz—Chest pain—Doxorubicin—urinary bladder cancer	0.000439	0.000496	CcSEcCtD
Guanabenz—Arthralgia—Doxorubicin—urinary bladder cancer	0.000439	0.000496	CcSEcCtD
Guanabenz—Myalgia—Doxorubicin—urinary bladder cancer	0.000439	0.000496	CcSEcCtD
Guanabenz—Anxiety—Doxorubicin—urinary bladder cancer	0.000438	0.000495	CcSEcCtD
Guanabenz—Paraesthesia—Methotrexate—urinary bladder cancer	0.000436	0.000493	CcSEcCtD
Guanabenz—Discomfort—Doxorubicin—urinary bladder cancer	0.000434	0.00049	CcSEcCtD
Guanabenz—Anorexia—Epirubicin—urinary bladder cancer	0.000434	0.00049	CcSEcCtD
Guanabenz—Dyspnoea—Methotrexate—urinary bladder cancer	0.000433	0.00049	CcSEcCtD
Guanabenz—Dry mouth—Doxorubicin—urinary bladder cancer	0.000429	0.000485	CcSEcCtD
Guanabenz—Dyspepsia—Methotrexate—urinary bladder cancer	0.000428	0.000484	CcSEcCtD
Guanabenz—Hypotension—Epirubicin—urinary bladder cancer	0.000425	0.000481	CcSEcCtD
Guanabenz—Confusional state—Doxorubicin—urinary bladder cancer	0.000424	0.00048	CcSEcCtD
Guanabenz—Decreased appetite—Methotrexate—urinary bladder cancer	0.000423	0.000478	CcSEcCtD
Guanabenz—Oedema—Doxorubicin—urinary bladder cancer	0.000421	0.000476	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00042	0.000474	CcSEcCtD
Guanabenz—Fatigue—Methotrexate—urinary bladder cancer	0.000419	0.000474	CcSEcCtD
Guanabenz—Infection—Doxorubicin—urinary bladder cancer	0.000418	0.000473	CcSEcCtD
Guanabenz—Pain—Methotrexate—urinary bladder cancer	0.000416	0.00047	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000414	0.000469	CcSEcCtD
Guanabenz—Shock—Doxorubicin—urinary bladder cancer	0.000414	0.000468	CcSEcCtD
Guanabenz—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000413	0.000467	CcSEcCtD
Guanabenz—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000412	0.000466	CcSEcCtD
Guanabenz—Tachycardia—Doxorubicin—urinary bladder cancer	0.000411	0.000464	CcSEcCtD
Guanabenz—Skin disorder—Doxorubicin—urinary bladder cancer	0.000409	0.000462	CcSEcCtD
Guanabenz—Paraesthesia—Epirubicin—urinary bladder cancer	0.000408	0.000462	CcSEcCtD
Guanabenz—Dyspnoea—Epirubicin—urinary bladder cancer	0.000406	0.000458	CcSEcCtD
Guanabenz—Anorexia—Doxorubicin—urinary bladder cancer	0.000401	0.000454	CcSEcCtD
Guanabenz—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000401	0.000453	CcSEcCtD
Guanabenz—Dyspepsia—Epirubicin—urinary bladder cancer	0.0004	0.000453	CcSEcCtD
Guanabenz—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000397	0.000449	CcSEcCtD
Guanabenz—Decreased appetite—Epirubicin—urinary bladder cancer	0.000395	0.000447	CcSEcCtD
Guanabenz—Hypotension—Doxorubicin—urinary bladder cancer	0.000393	0.000445	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000393	0.000444	CcSEcCtD
Guanabenz—Fatigue—Epirubicin—urinary bladder cancer	0.000392	0.000443	CcSEcCtD
Guanabenz—Pain—Epirubicin—urinary bladder cancer	0.000389	0.00044	CcSEcCtD
Guanabenz—Constipation—Epirubicin—urinary bladder cancer	0.000389	0.00044	CcSEcCtD
Guanabenz—Urticaria—Methotrexate—urinary bladder cancer	0.000386	0.000437	CcSEcCtD
Guanabenz—Abdominal pain—Methotrexate—urinary bladder cancer	0.000384	0.000434	CcSEcCtD
Guanabenz—Body temperature increased—Methotrexate—urinary bladder cancer	0.000384	0.000434	CcSEcCtD
Guanabenz—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000383	0.000434	CcSEcCtD
Guanabenz—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000378	0.000427	CcSEcCtD
Guanabenz—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000375	0.000424	CcSEcCtD
Guanabenz—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000375	0.000424	CcSEcCtD
Guanabenz—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000372	0.000421	CcSEcCtD
Guanabenz—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00037	0.000419	CcSEcCtD
Guanabenz—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000366	0.000414	CcSEcCtD
Guanabenz—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000363	0.000411	CcSEcCtD
Guanabenz—Fatigue—Doxorubicin—urinary bladder cancer	0.000363	0.00041	CcSEcCtD
Guanabenz—Urticaria—Epirubicin—urinary bladder cancer	0.000361	0.000409	CcSEcCtD
Guanabenz—Constipation—Doxorubicin—urinary bladder cancer	0.00036	0.000407	CcSEcCtD
Guanabenz—Pain—Doxorubicin—urinary bladder cancer	0.00036	0.000407	CcSEcCtD
Guanabenz—Abdominal pain—Epirubicin—urinary bladder cancer	0.00036	0.000407	CcSEcCtD
Guanabenz—Body temperature increased—Epirubicin—urinary bladder cancer	0.00036	0.000407	CcSEcCtD
Guanabenz—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000358	0.000405	CcSEcCtD
Guanabenz—Asthenia—Methotrexate—urinary bladder cancer	0.000349	0.000394	CcSEcCtD
Guanabenz—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000347	0.000392	CcSEcCtD
Guanabenz—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000344	0.000389	CcSEcCtD
Guanabenz—Pruritus—Methotrexate—urinary bladder cancer	0.000344	0.000389	CcSEcCtD
Guanabenz—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000335	0.000379	CcSEcCtD
Guanabenz—Urticaria—Doxorubicin—urinary bladder cancer	0.000334	0.000378	CcSEcCtD
Guanabenz—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000333	0.000376	CcSEcCtD
Guanabenz—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000333	0.000376	CcSEcCtD
Guanabenz—Diarrhoea—Methotrexate—urinary bladder cancer	0.000333	0.000376	CcSEcCtD
Guanabenz—Asthenia—Epirubicin—urinary bladder cancer	0.000326	0.000369	CcSEcCtD
Guanabenz—Pruritus—Epirubicin—urinary bladder cancer	0.000322	0.000364	CcSEcCtD
Guanabenz—Dizziness—Methotrexate—urinary bladder cancer	0.000321	0.000363	CcSEcCtD
Guanabenz—Diarrhoea—Epirubicin—urinary bladder cancer	0.000311	0.000352	CcSEcCtD
Guanabenz—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00031	0.000351	CcSEcCtD
Guanabenz—Vomiting—Methotrexate—urinary bladder cancer	0.000309	0.000349	CcSEcCtD
Guanabenz—Rash—Methotrexate—urinary bladder cancer	0.000306	0.000346	CcSEcCtD
Guanabenz—Dermatitis—Methotrexate—urinary bladder cancer	0.000306	0.000346	CcSEcCtD
Guanabenz—Headache—Methotrexate—urinary bladder cancer	0.000305	0.000344	CcSEcCtD
Guanabenz—Asthenia—Doxorubicin—urinary bladder cancer	0.000302	0.000341	CcSEcCtD
Guanabenz—Dizziness—Epirubicin—urinary bladder cancer	0.000301	0.00034	CcSEcCtD
Guanabenz—Pruritus—Doxorubicin—urinary bladder cancer	0.000298	0.000337	CcSEcCtD
Guanabenz—Vomiting—Epirubicin—urinary bladder cancer	0.000289	0.000327	CcSEcCtD
Guanabenz—Nausea—Methotrexate—urinary bladder cancer	0.000289	0.000326	CcSEcCtD
Guanabenz—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000288	0.000326	CcSEcCtD
Guanabenz—Rash—Epirubicin—urinary bladder cancer	0.000287	0.000324	CcSEcCtD
Guanabenz—Dermatitis—Epirubicin—urinary bladder cancer	0.000287	0.000324	CcSEcCtD
Guanabenz—Headache—Epirubicin—urinary bladder cancer	0.000285	0.000322	CcSEcCtD
Guanabenz—Dizziness—Doxorubicin—urinary bladder cancer	0.000278	0.000315	CcSEcCtD
Guanabenz—Nausea—Epirubicin—urinary bladder cancer	0.00027	0.000305	CcSEcCtD
Guanabenz—Vomiting—Doxorubicin—urinary bladder cancer	0.000268	0.000303	CcSEcCtD
Guanabenz—Rash—Doxorubicin—urinary bladder cancer	0.000265	0.0003	CcSEcCtD
Guanabenz—Dermatitis—Doxorubicin—urinary bladder cancer	0.000265	0.0003	CcSEcCtD
Guanabenz—Headache—Doxorubicin—urinary bladder cancer	0.000264	0.000298	CcSEcCtD
Guanabenz—Nausea—Doxorubicin—urinary bladder cancer	0.00025	0.000283	CcSEcCtD
